Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Rome
Clinical trial register · Italy

Clinical Trials in Rome, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 98 Roma 43 Naples 40 Rome 40 Rozzano 27
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS171 Hoffmann-La Roche73 AbbVie56 Merck Sharp & Dohme LLC40 Sanofi30 Clear sponsor filter
Site location
Milan98 Roma43 Naples40 Rome40 Rozzano27
All 66 locations
Target enrolment
to

Trials with a site in Rome

40 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Rome, Milan
2026-06-18
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
340
Bergamo, Rome
2026-05-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Naples, Rome, Milan, Rozzano, Orbassano, Florence, Castelfranco Veneto, Peschiera del Garda
2025-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Bolzano, Modena, Meldola, Udine, Rome, Bergamo, Rozzano, Statte
2025-10-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Milan, Rozzano, Rome, Siena, Arezzo, Bergamo, Foggia, Terni
2025-05-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Rome, Bologna, Genova, Milan, Novara, Padova, Roma
2025-03-16
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Milan, Rome, Arezzo, Roma
2025-03-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Catanzaro, Ravenna, Rome, Milan, Naples, Padova, Verona
2024-10-21
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
DrugZilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 1/2
90
Milan, Rome, Torino
2024-08-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Rome, Milan, Turin, Catania
2024-08-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Naples, Misterbianco, Meldola (FC), Aviano, Rome, Brescia, Milan, Monza
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Naples, Rome, Milan, Monza, Rozzano, Brescia, Genova, Novara
2024-06-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bari, Monserrato, Rome, Milan, Rozzano, Naples, Turin, Pontedera
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Naples, Ravenna, Aviano, Rome, Milan, Livorno, Padova
2024-05-24
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Rome, Milan, Rozzano, Verona
2024-05-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Naples, Rome, Milan, Pisa
2024-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Rome, Milan, Florence, Parma
2024-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Misterbianco, Meldola, Milan, Monza, Rome, Florence, Bergamo, Genova
2024-04-03
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Rome, Genoa, Milan, Naples
2024-03-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bologna, Aviano, Rome, Milan, Rozzano, Candiolo, Bari, Brescia
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Meldola, Rome, Milan, Rozzano
2023-11-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Monserrato, San Giovanni Rotondo, Rome, Milan, Rozzano, Rho, Naples, Palermo
2023-10-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Cona, Rome, Bergamo, Brescia, Milan, Monza, Turin, Palermo
2023-10-09
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Genoa, Milan, Turin, Rome, Florence, Padova
2023-05-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Rome, Bergamo, Milan, Naples, Florence, Peschiera del Garda, Parma
2023-02-06
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Rome, Milan, Palermo, Florence, Alessandria
2022-07-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Naples, Milan, Rozzano, Rome
2022-03-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Bari, Meldola, Rome, Milan, Orbassano, Florence, Arezzo, Bologna
2022-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Naples, Bologna, Meldola, Milan, Turin, Rome, Florence, Vicenza
2022-02-03
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Rome
2021-11-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Rome, Milan, Pavia
2021-09-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Rome, Milan, Monza, Rozzano, Bari, Catania, Naples, Padova
2021-06-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
815
Monza, Milan, Rome, Naples
2021-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Modena, Rome, Bari, Milan, Naples, Terni
2021-04-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Roma, Rome, Milan, Candiolo, Brescia, Naples, Padova
2021-01-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Torrette, Rome, Rozzano, Florence, Lecce, Milan, Modena, Udine
2020-07-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Bari, Rome, Milan, Florence, Modena, Naples, Province of Macerata
2020-05-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Rome, Padova, Bari, Catania, Roma
2020-02-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Bologna, Rome, Milan, Monza, Rozzano, Aviano, Catania, Candiolo
2018-08-21
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
370
Rome
2015-03-19
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/rome

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies with a site in Rome that also match the filters currently applied.

How many clinical trials are recruiting in Rome?

19 of the 40 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Rome), 40 studies
PhaseStudiesRecruitingShare
Phase 3301375%
Phase 1/24310%
Phase 24110%
Phase 2/3225%

Most active sponsors

Lead sponsors with the most studies (Rome)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC4019
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.